Learn How PCF Research Saves Men's Lives
BREAKING NEWS!: FDA Approves Apalutamide (Erleada) for the treatment of metastatic hormone-sensitive prostate cancer. Read More.
The 26th Annual Scientific Retreat
Never Give In Wristbands
Why Give to PCFHome
How one family’s journey to help fund research in memory of their daughter led them to PCF’s team science awards.
Read moreAmbassador Dax Shepard teaches us all a lesson about screening for prostate cancer
WatchThe prostate cancer foundation has used a laser-like strategy to reduce death from prostate cancer, but the journey to a cure continues.
Read MoreFind out more about prostate cancer risks, screening and how you can help the man in your life.
Learn MoreRead about results presented from the 2019 American Society of Clinical Oncology (ACSO) Annual Meeting.
Learn MorePatient Stephen Eisenmann talks about how PCF funded research helped him eradicate metastatic disease, thanks to generous donors like you.
Read MoreDime City Cycles and For The Bold built this motorcycle to fund prostate cancer research. Watch the build and donate $5 for a chance to take it home.
Enter to winWe are in a race for patients. For your husbands and fathers. For your sons ... and now your daughters.
Nobody wants to think about cancer, especially prostate cancer. Nobody wants to get screened, and especially, nobody wants to even think about getting a rectal exam to check for prostate cancer. We get that.
Precision ScreeningIn the upside down world of prostate cancer, the good guys want to win the war and the bad guys are leading the resistance. Imagine Rick’s Café in Casablanca, except it’s the bad guys, with a...
Genetic CounselingImmunotherapySurgery or radiation treatment for localized prostate cancer doesn’t mean that your sex life has to be over. But a big part of this may be up to you – and it’s not just that part....
Side EffectsIn the United States, men of African descent are more likely to develop prostate cancer than any other race or ethnicity.
African DescentOne of PCF's goals is to support transformational prostate cancer research to accelerate progress towards the reduction of death and suffering due to recurrent or advanced...
In 1993, PCF created a Competitive Awards program that revolutionized the evaluation and funding of prostate cancer research. Fortune magazine credited PCF with creating the “modern venture philanthropy” model for cancer research—citing the transformative power of PCF’s short grant applications and rapid funding. The awards empowered many young scientists to fill the pipeline...
For Researchers
The Prostate Cancer Foundation (PCF) is the world’s leading philanthropic organization dedicated to funding life-saving cancer research. Founded in 1993 by Mike Milken, PCF has raised more than $800 million in support of cutting-edge research by more than 2,200 research projects at 220 leading cancer centers in 22 countries around the world. Thanks in part to PCF’s commitment to ending death and suffering from prostate cancer, the death rate is down more than 50% and countless more men are alive today as a result. PCF research now impacts more than 70 forms of human cancer by focusing on immunotherapy, the microbiome, and food as medicine.
Learn more about our foundation